Related Experiment Video
Updated: May 13, 2025
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.5K
Challenges and opportunities in microRNA-based cancer therapeutics
1Department of Pathology, Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook, NY 11794-8691, USA.
Cell Reports. Medicine
|April 16, 2025
Summary
Nobel Prize-winning microRNA (miRNA) research highlights their biological importance. However, challenges remain in developing FDA-approved miRNA cancer therapies for clinical oncology.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) play crucial roles in fundamental biological processes and human health.
- Recent Nobel Prize recognition underscores the significance of miRNA discoveries.
- Despite therapeutic promise, no miRNA-based cancer therapies are currently FDA-approved.
Purpose of the Study:
- To discuss the advancements in miRNA-based cancer therapeutics.
- To identify the challenges hindering the clinical application of miRNA therapies.
- To explore the future impact of miRNAs on clinical oncology.
Main Methods:
- Literature review and synthesis of current research on miRNA therapeutics.
- Analysis of progress and obstacles in preclinical and clinical miRNA studies.
- Discussion of regulatory and technical hurdles for miRNA drug development.
Main Results:
- Significant progress has been made in understanding miRNA functions in cancer.
- Key challenges include delivery methods, off-target effects, and stability of miRNA therapeutics.
- The therapeutic potential of miRNAs in oncology remains substantial but largely unrealized.
Conclusions:
- Overcoming current challenges is essential for translating miRNA discoveries into effective cancer treatments.
- Continued research and development are needed to advance miRNA-based cancer therapies.
- miRNAs hold promise for revolutionizing future clinical oncology strategies.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
8.2K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
Related Concept Videos
01:22MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:30siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K